Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Catecholamine prodrugs for use in the treatment of Parkinson's disease

Catecholamine prodrugs for use in the treatment of Parkinson's disease

US Patent 11110110 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahy2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease2025
Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease2025
Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Catecholamine prodrugs for use in the treatment of Parkinson's Disease2025